YDES
Yd Bio Ltd
NASDAQ · Biotechnology
$11.28
+0.52 (+4.83%)
Open$11.22
Previous Close$10.76
Day High$11.78
Day Low$11.01
52W High$25.00
52W Low$7.20
Volume—
Avg Volume38.7K
Market Cap807.84M
P/E Ratio—
EPS$-1.03
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 515.6K | 122.20M | 119.09M |
| Net Income | -1,432,336 | 29.08M | 25.78M |
| Profit Margin | -276.6% | 23.8% | 21.7% |
| EBITDA | -1,410,851 | 41.35M | 38.15M |
| Free Cash Flow | — | 33.20M | 25.74M |
| Rev Growth | — | +2.9% | +5.6% |
| Debt/Equity | 0.01 | 0.45 | 0.33 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |